| CONFERENCE PARTICIPANTS
|
From the UK
Almac Diagnostics
AstraZeneca, UK
Averion International
Axis-Shield Diagnostics
BioPartner.co.uk
Compandia Ltd
Datatrial
High Force Research Ltd
INC Research
Integrated Medicines
Lab21 Healthcare
Medidata
Nextgen Sciences
Oxford Gene Technology
Penn Pharma
Pharmalicensing
Premier Research
Price Waterhouse Coopers
Qiagen UK Ltd. (DxS)
Scottish Development International
Source Bioscience
TEVA Pharmaceutical Industries Ltd
The Clinical Trial Company
The Institute of Cancer Research
The Technology Partnership plc
Theradex (Europe) Ltd
Trillion Genomics Ltd
University of Portsmouth
|
From the Nordics
2cureX
aCROnordic a/s
Biopeople
Biotec Pharmacon ASA
CMC Contrast AB
Copenhagen Capacity
CytoTrack ApS
Dako Denmark A/S
DanDrit Biotech A/S
Diagenic ASA
Exiqon A/S
FluimediX
Genomic Expression
i3 Research
Innovation Team
Insightasy AB
KaroBio
Kuros ApS
Medical Prognosis Institute
MicroMorph AB
Novo Nordisk
Olink
Oncos Therapeutics
Phase Holographic Imaging
Pipeline Biotech
Plexpress Oy
Scandinavian Life Science Invest AB
SEED Capital Denmark
Smerud Medical Research
TECTRA
TFS Trial Form Support AB
TopoTarget A/S
University of Copenhagen
ValaMed
Wiborg ApS
|
To find out more about the Conference, please contact Project Manager, Christina Bergstrand, at +46-86713065 or cb@britishembassy.se
|
|